GPC3 is a glycoprotein expressed in most hepatocellular carcinoma (HCC) patients with minimal expression in normal and cirrhotic liver tissue, making it a suitable target for CAR-T cell therapy [66]. Here, GPC3 is linked to hepatocellular carcinoma.